CASE REPORT

Hydroxyurea induced Liver Injury with significant eosinophilia in a case of sickle cell anaemia

Mukul Rastogi.1 Rakesh Kumar Jagdish.2* 

• .1Department of Hepatology, Gastroenterology and Liver Transplant, Fortis Hospital, Noida 
• .2Department of Hepatology and Gastroenterology and Liver Transplant, Metro Hospital, Noida
•  

Corresponding Author: Rakesh Kumar Jagdish, Department of Hepatology, Gastroenterology and Liver Transplant, Fortis Hospital, Noida, India. E-mail: [email protected] 

Received: October 29, 2022                                                     Published: November 14, 2022 

Citation: Rakesh J. Hydroxyurea induced Liver Injury with significant eosinophilia in a case of sickle cell anaemia. Int J Complement Intern Med. 2022;2(1):62–65. 

Copyright: ©2022 Jagdish. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and build upon your work non-commercially.

Abbreviations 

HU: hydroxyurea, LFT: Liver function tests, HRCT: High resolution computed tomography, DILI: Drug induced Liver Injury, RUCAM: Roussel Uclaf Causality Assessment Method, SCD: Sickle cell diseases. 

Keywords: Hydroxyurea, Drug induced Liver Injury, RUCAM, Sickle cell diseases, Sickle Hepatopathy, Eosinophilia

References 

1. Ahn H, Li CS, Wang W. Sickle cell hepatopathy: clinical presentation, treatment, and outcome in pediatric and adult patients. Pediatr Blood Cancer. 2005;45(2):184–190. 

2. Shah R, Taborda C, Chawla S. Acute and chronic hepatobiliary manifestations of sickle cell disease: A review. World J Gastrointest Pathophysiol. 2017;8(3):108 –116. 

3. Al Suleiman AM, Bu sobaih J. Acute fulminant cholestatic jaundice in sickle cell disease. Ann Saudi Med. 2006;26(2):138 –140. 

4. Bandyopadhyay R, Bandyopadhyay SK, Dutta A. Sickle cell hepatopathy. Indian J PatholMicrobiol. 2008;51(2):284 –295. 

5. Hallam MJ, Kolesar JM. Hydroxyurea induced acute elevations in liver function tests. J Oncol Pharm Pract. 2008;14(1):61 –63. 

6. KwunLui S, Krasinskas A, Shah R. Orthotropic Liver Transplantation for Acute Intrahepatic Cholestasis in Sickle Cell Disease: Clinical and Histopathologic Features of a Rare Case. Int J SurgPathol. 2019;27(4):411 –417. 

7. Canalli AA, Conran N, Fattori A. Increased adhesive properties of eosinophils in sickle cell disease. ExpHematol. 2004;32(8):728 –734. 

8. FR Pallis, N Conran, KY Fertrin. Altered Functional Properties of Eosinophils in Sickle Cell Anemia and Effects of Hydroxyurea Therapy. Blood. 2010;116 (21): 2656. 

9. Havlir DV, Gilbert PB, Bennett K. ACTG 5025 Study Group. Effects of treatment intensification with hydroxyurea in HIV –infected patients with virologic suppression. AIDS. 2001;27:1379–1388. 

10. Sulkowski MS, Thomas DL, Moore RD. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA. 2000;283:74–80. 

11. Westerman DA, Schwarer A, Grigg AP. Hydroxyurea – induced fever and hepatitis. Aust N Z J Med. 1998;28: 657–659. 

12. Heddle R, Calvert AF. Hydroxyurea induced hepatitis. Med J Aust. 1980;1:121. 

13. Sharon R, Tatarsky I, Ben Arieh Y. Treatment of Polycythemia Vera with Hydroxyurea. Cancer. 1986;57:718–720. 

14. Malec J, Szczepanska I, Grabarczyk M. Hydroxyurea –induced toxic side –effects in animals and an attempt at reducing them with vitamins E and C. Neoplasma. 1989;36:427–435.